SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ·Healthcare·Biotechnology
$10.25
-5.42%
Mkt Cap $2.30B
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (3 analysts)
$25.00
Range $25.00 – $25.00
Implied Upside
+144.0%
Consensus $25.00 vs current $10.25
NASDAQ·Healthcare·Biotechnology
$10.25
-5.42%
Mkt Cap $2.30B
Buy
1
Hold
0
Sell
0
Price Target (3 analysts)
$25.00
Range $25.00 – $25.00
+144.0%
Consensus $25.00 vs current $10.25